ArticlePharmacoEconomics - open2021

Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis.

Machaon Bonafede et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.